Skip to main content

Table 2 Fasting serum lipid levels of successfully genotyped normoglycemic and hyperglycemic Danes from the Inter99 cohort stratified according to ACADS rs2014355 genotype

From: The minor C-allele of rs2014355 in ACADSis associated with reduced insulin release following an oral glucose load

 

WT

HE

HO

β (95% CI)

P add

Normoglycemic

n (men/women)

2576(1208/1368)

1496(694/802)

252(105/147)

  

Age (years)

45.2 ± 7.8

45.4 ± 7.9

44.9 ± 7.9

  
 

Lipid characteristics (mmol/l)

  

Total serum cholesterol

5.4 ± 1.0

5.4 ± 1.0

5.4 ± 1.1

0.001 (-0.046; 0.048)

0.97

HDL-cholesterol

1.5 ± 0.4

1.5 ± 0.4

1.5 ± 0.4

0.002 (-0.016; 0.019)

0.86

LDL-cholesterol

3.5 ± 1.0

3.5 ± 1.0

3.5 ± 1.0

-0.001 (-0.065; 0.063)

0.97

VLDL-cholesterol

0.5 ± 0.3

0.6 ± 0.3

0.5 ± 0.2

0.007 (-0.012; 0.026)

0.46

Serum triglyceride

1.0 (0.7-1.4)

1.0 (0.7-1.4)

1.0 (0.7-1.3)

0.5% (-1.8%; 2.7%)

0.69

Hyperglycemic

n (men/women)

804(473/331)

496(306/190)

78(49/29)

  

Age (years)

48.8 ± 7.4

49.4 ± 7

47.8 ± 8.1

  
 

Lipid characteristics (mmol/l)

  

Total serum cholesterol

5.8 ± 1.1

5.9 ± 1.2

5.9 ± 1.2

0.09 (-0.01;0.19)

0.08

HDL-cholesterol

1.4 ± 0.4

1.3 ± 0.4

1.3 ± 0.5

-0.036 (-0.067; -0.005)

0.02

LDL-cholesterol

3.7 ± 1.0

3.7 ± 1.0

3.9 ± 1.4

0.06 (-0.07; 0.19)

0.38

VLDL-cholesterol

0.7 ± 0.4

0.7 ± 0.4

0.8 ± 0.4

0.03 (-0.02; 0.08)

0.21

Serum triglyceride

1.4 (0.9-2.0)

1.4 (1.1-2.0)

1.5 (1.1-2.6)

5.2% (0.4%; 10.0%)

0.03

  1. Data are unadjusted means ± SD or medians (interquartile range). Values of serum triglycerides were logarithmically transformed before statistical analysis, and their effect sizes are presented as the increase/decrease in percent. Normoglycemic: glucose-tolerant individuals from the Inter99 cohort. Hyperglycemic: individuals with IFG, IGT or screen-detected T2D from the Inter99 cohort. All analyses were made using an additive genetic model, adjusting for age, sex, and BMI. ACADS rs2014355 genotypes: WT, homozygous major T-allele carriers; HE, heterozygous; HO, homozygous minor C-allele carriers.